Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 2 recruiting now early-phase tilt small index

Cardiac Failure: early-phase trial registry

2 of 5 indexed Cardiac Failure trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #3,391 of 28,707 conditions by registered trial count.

5 US clinical trials · 2 currently recruiting · #3,391 of 28,707 conditions by registered trial count

Cardiac Failure: 5 US clinical trials tracked, 2 recruiting.

Cardiac Failure is the subject of 5 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Inova Health Care Services, running 2 of these trials.

Enrollment posture brief

Registry condition cardiac-failure

OPEN 2 | RECR 40% | LATE 0 | EARLY 1 | RANK #3391 | SPON 2

Nearest open-share peer: Achondroplasia (40% recruiting · 10 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Cardiac Failure (this)40%
Open-enrollment share among volume-matched conditions near Cardiac Failure

Cardiac Failure lists 2 open slots (40% of 5 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Cardiac Failure on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Cardiac Failure is recruiting below its size-band peers.

    2 of 5 indexed trials (40%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Cardiac Failure research.

    Inova Health Care Services accounts for 2 of 5 trials (40%). 4 distinct sponsors appear on at least one study for this condition label.

  3. Typical Cardiac Failure enrolment sits around 150 participants.

    Median target enrolment is 150 among the 5 trials that report a genuine target (sentinel values excluded). 2 of those (40%) plan for fewer than 100 participants.

  4. Cardiac Failure research leans observational.

    2 interventional and 3 observational studies make up this index (40% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 21

Phase Distribution

PhaseTrial count
Phase 2 1

Named interventions

Most-linked intervention names on Cardiac Failure records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Diagnostic Test: Myostrain Procedure
1 trials
Self-Management Education for Heart Failure Behavioral
1 trials
Nitroglycerin (NTG) Drug
1 trials
HNO Donor Drug
1 trials
Cognitive Behavioral Therapy for Insomnia Behavioral
1 trials
Placebo Other
1 trials

US sites by state

Facility locations filed on Cardiac Failure trials. A trial with sites in several states counts in each.

Virginia 3 trials
Texas 2 trials
Tennessee 2 trials
California 2 trials
South Carolina 1 trials
Pennsylvania 1 trials
New York 1 trials
North Carolina 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Cardiac Failure page

5 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Cardiac Failure condition card totals 5 registered trials; most-linked intervention Diagnostic Test: Myostrain; top US site state Virginia. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.